Total (n = 123) | Pharmacists as first authors (n = 39) | Non-pharmacists as first authors (n = 84) | P-value | |
---|---|---|---|---|
Intervention | 56 (45.5) | 23 (59.0) | 33 (39.3) | 0.041 |
TDM | 2 (1.6) | 2 (5.1) | 0 (0) | 0.099 |
Surveillance | 40 (32.5) | 8 (20.5) | 32 (38.1) | 0.053 |
Efficacy and adverse event | 8 (6.5) | 2 (5.4) | 6 (7.6) | > 0.99 |
Case report | 0 | 0 | 0 | – |
PBPM | 0 | 0 | 0 | – |
Other | 17 (13.8) | 4 (10.3) | 13 (15.5) | 0.435 |